41
total announcements
JSLL.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹4,597 Cr
P/E (TTM)
19.5
P/E (Forward)
10.3
EPS (TTM)
₹18.98
52W Low
₹359.75
52W High
₹835.00
Dividend Yield
1.16%
Beta
1.04
Price / Book
9.8
Debt / Equity
27.3
Revenue (TTM)
₹851 Cr
Gross Margin
88.39%
Operating Margin
34.17%
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has allotted 23,374 equity shares under the Employee Stock Option Scheme 2024, increasing the paid-up equity share capital from Rs. 24,86,01,460 to Rs. 24,86,48,208.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has submitted a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half-year ended September 30, 2026.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has launched 7 new Ayurvedic healthcare, wellness and nutraceutical products, expanding its portfolio and strengthening its presence in the domestic market.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has received NABH accreditation for its Raipur hospital, adhering to nationally recognized standards for quality healthcare delivery, patient safety, and operational excellence.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has announced the voting results and scrutinizer's report of its 9th Annual General Meeting (AGM), which was held on September 28, 2026. The meeting saw a total of 124,300,730 votes cast, with all resolutions passed with a high percentage of votes in favor.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd's promoter, Bhavna Grover, has acquired 25,000 shares through open market purchase, increasing her stake to 0.24%.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has made a disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, regarding the purchase of 25,000 equity shares by promoter Bhavna Grover through the open market on 29th September 2026.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has disclosed under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, that promoter Bhavna Grover has purchased 35,000 equity shares through the open market on 28th September, 2026.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd's promoter Bhavna Grover has acquired 35,000 shares through open market purchase, increasing her stake from 0.20% to 0.22%.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd held its 9th Annual General Meeting on September 28, 2026, where the company's financial statements for FY 2025-2026 were adopted, a final dividend of ₹4.50 per equity share was declared, and several board appointments were made.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has announced the closure of the trading window for its directors, KMPs, connected persons, and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ended September 30, 2026.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has received in-principle approval from BSE Limited for listing up to 6,50,000 equity shares under the Jeena Sikho Employees Stock Option Scheme, 2024.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has announced its participation in the 'Bharat Connect Conference: Rising Stars – March 2026' hosted by Arihant Capital Markets Limited on September 29, 2026. The management will engage in a virtual meeting to discuss publicly available documents, with no unpublished price-sensitive information intended to be discussed.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has announced the launch of six new products under its Ayurvedic, healthcare and wellness product portfolio, including Narie Xpert Granules 80g, Narie Xpert Syrup 500 Ml, Narie Xpert Tablet 52 Tab, Porush Xpert Granules 80g, Porush Xpert Syrup 500 Ml, and Porush Xpert Tablet 52 Tab. The products are expected to be launched on 02nd September 2026.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has fixed the date of its 9th Annual General Meeting (AGM) for September 28, 2026, and has recommended a final dividend of ₹4.50 per equity share for the FY 2025-26. The Board has also appointed a Scrutinizer to oversee the remote e-voting process and the voting process at the AGM.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has fixed Monday, 21st September, 2026 as the Record date for Dividend, if declared. The company has also announced the 9th Annual General Meeting (AGM) on Monday, September 28, 2026.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has fixed Monday, 21st September, 2026 as the Record Date for determining the eligibility of members entitled to receive the final dividend, if declared at the 9th AGM.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd announced the outcome of its Board meeting, where it approved the Annual Report for FY 2025-26, fixed the date for the 9th AGM, and declared a final dividend of ₹4.50 per equity share. The company also fixed the book closure period from September 22 to 28, 2026, and the record date for the final dividend as September 21, 2026.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has announced the outcome of its board meeting, where it approved the annual report for FY 2025-26, fixed the date of the 9th AGM, and declared a final dividend of ₹4.50 per equity share. The record date for the final dividend has been fixed as Monday, 21st September, 2026.
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd has informed about an analyst/investor meet under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, scheduled to be held on 3rd September 2026 at Grand Hyatt, Santacruz, Mumbai.